Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14748-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14748-1-AP, RRID:AB_2170472
- Product name
- PSMD2 antibody
- Antibody type
- Polyclonal
- Description
- PSMD2 antibody (Cat. #14748-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references DNAJA4 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma via PSMD2-mediated MYH9 degradation.
Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.
The Identification of Nuclear FMRP Isoform Iso6 Partners.
Rapamycin inhibits hepatitis B virus covalently closed circular DNA transcription by enhancing the ubiquitination of HBx.
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.
The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates.
PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism.
NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma.
The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Cancer vulnerabilities unveiled by genomic loss.
Zhang Q, Feng P, Zhu XH, Zhou SQ, Ye ML, Yang XJ, Gong S, Huang SY, Tan XR, He SW, Li YQ
Cell death & disease 2023 Oct 24;14(10):697
Cell death & disease 2023 Oct 24;14(10):697
Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.
Bai Y, Zhou L, Zhang C, Guo M, Xia L, Tang Z, Liu Y, Deng S
Oncogene 2023 Dec;42(49):3605-3618
Oncogene 2023 Dec;42(49):3605-3618
The Identification of Nuclear FMRP Isoform Iso6 Partners.
Ledoux N, Lelong EIJ, Simard A, Hussein S, Adjibade P, Lambert JP, Mazroui R
Cells 2023 Dec 9;12(24)
Cells 2023 Dec 9;12(24)
Rapamycin inhibits hepatitis B virus covalently closed circular DNA transcription by enhancing the ubiquitination of HBx.
Zhang Y, Li L, Cheng ST, Qin YP, He X, Li F, Wu DQ, Ren F, Yu HB, Liu J, Chen J, Ren JH, Zhang ZZ
Frontiers in microbiology 2022;13:850087
Frontiers in microbiology 2022;13:850087
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.
Gu C, Wang Y, Zhang L, Qiao L, Sun S, Shao M, Tang X, Ding P, Tang C, Cao Y, Zhou Y, Guo M, Wei R, Li N, Xiao Y, Duan J, Yang Y
Journal of experimental & clinical cancer research : CR 2022 Jan 6;41(1):11
Journal of experimental & clinical cancer research : CR 2022 Jan 6;41(1):11
The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates.
Pu M, Tai Y, Yuan L, Zhang Y, Guo H, Hao Z, Chen J, Qi X, Wang G, Tao Z, Ren J
Cellular and molecular life sciences : CMLS 2022 Aug 29;79(9):501
Cellular and molecular life sciences : CMLS 2022 Aug 29;79(9):501
PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism.
Tan Y, Jin Y, Wu X, Ren Z
BMC molecular biology 2019 Nov 8;20(1):24
BMC molecular biology 2019 Nov 8;20(1):24
NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma.
Zhou HZ, Zeng HQ, Yuan D, Ren JH, Cheng ST, Yu HB, Ren F, Wang Q, Qin YP, Huang AL, Chen J
Cell communication and signaling : CCS 2019 Dec 16;17(1):168
Cell communication and signaling : CCS 2019 Dec 16;17(1):168
The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A, Dayal S, Das J, Robertson P, Menendez S, Saville MK
Oncogene 2014 Sep 18;33(38):4685-96
Oncogene 2014 Sep 18;33(38):4685-96
Cancer vulnerabilities unveiled by genomic loss.
Nijhawan D, Zack TI, Ren Y, Strickland MR, Lamothe R, Schumacher SE, Tsherniak A, Besche HC, Rosenbluh J, Shehata S, Cowley GS, Weir BA, Goldberg AL, Mesirov JP, Root DE, Bhatia SN, Beroukhim R, Hahn WC
Cell 2012 Aug 17;150(4):842-54
Cell 2012 Aug 17;150(4):842-54
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PSMD2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PSMD2. This antibody recognizes human, mouse, rat antigen. The PSMD2 antibody has been validated for the following applications: ELISA, WB analysis.